| |
 |
General Partners
Paul
E. Tierney, Jr.
has been a highly respected global investment
professional for over thirty years. His experience
and relationships help Aperture’s portfolio
companies in a variety of valuable ways (strategy,
capital raising, M&A, business development,
corporate governance). Prior
to Aperture, Paul co-founded and ran Coniston
Partners and its successor partnerships throughout
the 1980s and 1990s. Financial, operational and
strategic decisions helped Paul build Coniston to
over $1 billion in capital and generate
significant returns to the shareholders and
limited partners. Paul also founded and ran other
investment vehicles, including Coniston Global
Partners, Corporate Value Partners and Darwin
Capital Partners, all of which generated superior
returns to shareholders. He serves on the Board of
Altea Therapeutics and is actively involved with
other portfolio companies of Aperture. He is
Chairman of the Board of TechnoServe, a non-profit
organization dedicated to promoting
entrepreneurship in Latin America and Africa, and
an Adjunct Professor at Columbia Business School teaching courses on private equity. He
is also a member of the Council on Foreign
Relations. He received his M.B.A. as a
Baker Scholar from Harvard Business School and a B.A. with high honors from the University of
Notre Dame.
Thomas P. Cooper, M.D. is a nationally recognized healthcare entrepreneur, having
used his medical training and business experience
to found several companies which have become the
national leaders in their respective fields and
generated $2 billion in revenues. His experience
and relationships help Aperture’s portfolio
companies in a variety of valuable ways
(operations, strategy, recruiting, regulatory,
reimbursement). Companies that Tom has
founded include a national emergency physician
company (Spectrum Emergency Care: Acquired by
Laidlaw, Inc.), the largest correctional facility
healthcare company (Correctional Medical Services)
and the largest provider of X-Ray/EKG to nursing
homes (Mobilex USA: Acquired by Integrated Health
Services). These companies have had combined
revenues of over $2 billion, serve over five
thousand facilities, are located in all 50 states
and reach more than four million patients. Tom
serves on the Boards of Cardiocore Lab, IPC The
Hospitalist Company and Kindred Healthcare and is
actively involved with other portfolio companies
of Aperture. He is an Adjunct Professor at
Columbia Business School teaching courses on
entrepreneurship. He received his M.D. from
Indiana University and his B.A. from DePauw
University.
Eric H. Sillman has worked at Aperture
since inception and is involved in all aspects of
the business. He is actively engaged with many of
Aperture’s portfolio companies. Prior to
Aperture, Eric worked in a variety of professional
services capacities. At UBS, he executed merger
and acquisition, equity and debt transactions in a
variety of industries. At The Parthenon Group, he
helped companies assess expansion strategies and
e-commerce initiatives. At TechnoServe, he
assisted early stage companies with market
analyses, financial management and organizational
structures and instituted a methodology to measure
organizational impact. He serves on the Board of
Agora Partnerships and on TechnoServe's Board of
Members. He received his M.B.A. from Harvard
Business School and B.A. from Brown University.
Advisory
Board
Paul
R. Charron retired as Chief Executive Officer of Liz Claiborne, Inc. in 2006, a
position he held since 1995.
From 1996-2006, Mr. Charron was also
Chairman of the Board.
He currently serves as an Advisor to
Warburg Pincus, LLC, the global private equity
group. Previously,
Mr. Charron was Executive Vice President of VF
Corporation, the country's largest publicly-held
apparel manufacturer.
Before joining VF in 1988, Mr. Charron
served as President and Chief Operating Officer of
Brown & Bigelow, the Minnesota-based
promotional products firm.
He also served as Senior Vice President,
Sales and Marketing at Cannon Mills Company, a New
York-based bath and bedding manufacturer, and
worked in marketing management positions at
General Foods Corporation.
His business career began in the brand
management organization at Procter & Gamble.
Mr. Charron currently serves on the boards
of the National Retail Federation, where he serves
as Second Vice Chairman, and the American Apparel
& Footwear Association, where he served as
Chairman. He
currently serves as a Director of Campbell Soup
Company and Vital Voices Global Partnership.
In addition, Mr. Charron is a member of the
American Society of Corporate Executives.
Mr. Charron is a graduate of Notre Dame University
and Harvard Business School.
Peter
A. Flaherty is a Director Emeritus of McKinsey & Company.
Mr. Flaherty served for many years on
McKinsey’s Investment Advisory Committee, which
is responsible for pension and discretionary
partner investments, with a particular focus on
alternative investments.
In June 2001, he moved to part-time status
with McKinsey to focus increasingly on private
investing and not-for-profit interests.
Since 2005, Mr. Flaherty has been a
Managing Director of Arcon Partners, a private
investment firm.
He is a member of the Boards of Rockefeller
University, The Foreign Policy Association, The
Kenyon Review, TechnoServe and the Leadership Academy
of the New York City Schools.
He is Chairman of the Advisory Council for
the Johns Hopkins School of Advanced International
Studies. He
is a member of the Board of Visitors of the
Institute for International Studies at Stanford University
and a member of the Council on Foreign Relations.
Mr. Flaherty is a graduate of Stanford University, the Johns Hopkins School of Advanced
International Studies and the Harvard Business School.
Keith
R. Gollust is a private investor and, along with Mr. P. Tierney, a founding partner
of Gollust, Tierney, and Oliver, a private
investment firm.
Mr. Gollust is Chairman of the Board of
Synta Pharmaceuticals, an emerging public
pharmaceutical company with a diverse pipeline of
drugs targeting large therapeutic markets.
He is also a member of the Advisory Board
of Blackstone Alternative Asset Management, a
director of The Juilliard School and a member of
the Advisory Council of the Princeton University
Department of Astrophysics.
Mr. Gollust is a graduate of Princeton University
and the Carnegie Mellon School of Business
Administration.
Edward
L. Kuntz is a leading healthcare executive in the United States, bringing deep industry knowledge and contacts.
He currently is Executive Chairman of
Kindred Healthcare, Inc., one of the largest
providers of long-term healthcare services in the United States. Kindred is a New York Stock Exchange listed
company with revenues in excess of $4 billion, and
is also a Fortune “500” company.
In January 2004, Mr. Kuntz relinquished his
position as CEO of Kindred, after serving as CEO
for more than five years.
Prior to Kindred, Mr. Kuntz was an advisor
to a number of healthcare companies and investment
groups, including a venture capital firm.
He was also CEO of Living Centers of America, a leading long-term healthcare company.
Mr. Kuntz began his career in the private
practice of law and then served as General Counsel
of ARA Services (now Aramark).
Mr. Kuntz serves as a director of Rotech
Healthcare and PharMerica.
He has been active in numerous professional
associations, including the Alliance for Quality Healthcare, the American Health Care
Association and the Federation of American
Hospitals. Mr.
Kuntz graduated magna cum laude with a Bachelor of
Arts degree and also received Juris Doctor and
Master of Law degrees from Temple University.
|
|